{"abstract":"This notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Cancer Institute (NCI), National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in the following U.S. Patents and Patent Applications to Heliome Biotech, Inc. (\"Heliome\") located in New York, NY, USA. Intellectual Property:","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2015/12/18/2015-31831.html","cfr_references":[],"citation":"80 FR 79052","comment_url":null,"comments_close_on":"2016-01-04","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the NCI Technology Transfer Center on or before January 4, 2016 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2015-31831","effective_on":null,"end_page":79052,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2015/12/18/2015-31831.xml","html_url":"https://www.federalregister.gov/documents/2015/12/18/2015-31831/prospective-grant-of-exclusive-license-development-of-a-small-molecule-farnesoid-x-receptor","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2015-31831?publication_date=2015-12-18","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2015-12-18/2015-31831/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":59,"last_updated":"2026-06-25 08:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2015-12-18/pdf/2015-31831.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2015-31831.pdf?1450359991","publication_date":"2015-12-18","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2015/12/18/2015-31831.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"checked_regulationsdotgov_at":"2023-03-01T06:12:13Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":79052,"subtype":null,"title":"Prospective Grant of Exclusive License: Development of a Small Molecule Farnesoid X Receptor Inhibitor","toc_doc":"Development of a Small Molecule Farnesoid X Receptor Inhibitor","toc_subject":"Exclusive Licenses:","topics":[],"type":"Notice","volume":80}